A detailed history of Price T Rowe Associates Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 9,351,590 shares of GBIO stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,351,590
Previous 9,513,626 1.7%
Holding current value
$12.8 Million
Previous $26.8 Million 13.9%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.16 - $3.51 $349,997 - $568,746
-162,036 Reduced 1.7%
9,351,590 $23.1 Million
Q2 2024

Aug 14, 2024

BUY
$2.64 - $4.35 $1.68 Million - $2.76 Million
635,265 Added 7.16%
9,513,626 $26.8 Million
Q1 2024

May 15, 2024

BUY
$1.73 - $4.07 $3.38 Million - $7.95 Million
1,952,187 Added 28.19%
8,878,361 $36.1 Million
Q4 2023

Feb 14, 2024

SELL
$0.91 - $3.35 $480,961 - $1.77 Million
-528,529 Reduced 7.09%
6,926,174 $11.4 Million
Q3 2023

Nov 14, 2023

SELL
$3.65 - $6.9 $144,105 - $272,418
-39,481 Reduced 0.53%
7,454,703 $28.3 Million
Q2 2023

Aug 14, 2023

SELL
$3.5 - $5.67 $525,038 - $850,562
-150,011 Reduced 1.96%
7,494,184 $41.2 Million
Q1 2023

May 15, 2023

BUY
$3.61 - $7.01 $1.38 Million - $2.69 Million
383,149 Added 5.28%
7,644,195 $32.9 Million
Q4 2022

Feb 14, 2023

SELL
$3.66 - $6.77 $492,368 - $910,747
-134,527 Reduced 1.82%
7,261,046 $28.5 Million
Q3 2022

Nov 14, 2022

SELL
$4.68 - $8.34 $7.19 Million - $12.8 Million
-1,536,040 Reduced 17.2%
7,395,573 $39.3 Million
Q2 2022

Aug 15, 2022

BUY
$4.87 - $9.41 $817,780 - $1.58 Million
167,922 Added 1.92%
8,931,613 $58.6 Million
Q1 2022

May 16, 2022

BUY
$4.16 - $7.76 $484,931 - $904,583
116,570 Added 1.35%
8,763,691 $64.3 Million
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $113,240 - $472,057
18,905 Added 0.22%
8,647,121 $61.2 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $25.3 Million - $34.7 Million
1,265,101 Added 17.18%
8,628,216 $216 Million
Q2 2021

Aug 16, 2021

BUY
$24.34 - $38.34 $21.4 Million - $33.7 Million
878,571 Added 13.55%
7,363,115 $198 Million
Q1 2021

May 17, 2021

BUY
$24.74 - $40.2 $51.7 Million - $84 Million
2,090,360 Added 47.57%
6,484,544 $185 Million
Q4 2020

Feb 16, 2021

BUY
$21.68 - $51.61 $95.3 Million - $227 Million
4,394,184 New
4,394,184 $125 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $80.8M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.